| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President and CEO
2 companies
Roger Pomerantz last filed a Form 4 in June 2025, as President and CEO at MCRB. The filings on record cover 2 companies. From June 2015 to November 2024, the filings on record show 0 open-market purchases and 19 sales. Roger Pomerantz's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 213,976 shares of MCRB. The MCRB filings lean toward selling, a net 824,466 shares.
Shares as reported in the last Form 4 for each company; the most recent is from June 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2016 | MCRB Seres Therapeutics, Inc. | President and CEO | Sale+OE | 56,789 | $29.81 | $1,692,704.72 | -23.6% | |
| Jun 2, 2016 | MCRB Seres Therapeutics, Inc. | President and CEO | Sale+OE | 74,049 | $32.52 | $2,407,915.67 | -28.7% | |
| Jun 1, 2016 | MCRB Seres Therapeutics, Inc. | President and CEO | Sale+OE | 70,951 | $30.51 | $2,164,837.85 | -27.9% | |
| May 24, 2016 | MCRB Seres Therapeutics, Inc. | President and CEO | Sale+OE | 9,801 | $30.00 | $294,030.00 | -5.1% | |
| May 6, 2016 | MCRB Seres Therapeutics, Inc. | President and CEO | Sale+OE | 8,507 | $24.31 | $206,802.52 | -27.2% | |
| May 5, 2016 | MCRB Seres Therapeutics, Inc. | President and CEO | Sale+OE | 59,325 | $26.13 | $1,550,277.92 | -72.3% | |
| May 3, 2016 | MCRB Seres Therapeutics, Inc. | President and CEO | Sale+OE | 67,367 | $28.70 | $1,933,196.89 | -74.8% | |
| Apr 7, 2016 | MCRB Seres Therapeutics, Inc. | President and CEO | Sale+OE | 9,212 | $30.00 | $276,360.00 | -28.8% | |
| Apr 4, 2016 | MCRB Seres Therapeutics, Inc. | President and CEO | Sale+OE | 135,788 | $27.20 | $3,693,795.49 | -85.7% |